Fennec, Cipla Resolve Patent Case Over Generic Pedmark Infusion

Fennec Pharmaceuticals Inc. reached a deal clearing the way for Cipla Ltd. to seek FDA approval of its copy of Pedmark, ending a case over patents for the hearing-loss treatment.

The parties asked the court to enter a consent judgment and injunction resolving the dispute as part of a separate license agreement, according to their joint stipulation filed Monday in the US District Court for the District of New Jersey. The filing didn’t disclose the terms of the license agreement.

The proposed consent judgment would dismiss all claims without prejudice and allow Cipla to seek the US Food and Drug ...